MYC and lymphoma: Although the Myc protein sequence remains unaltered in most cancers, exceptions occur in the above-cited lymphomas, where over half contain recurrent and often multiple Myc point mutations, which are generally confined to the N-terminal transcriptional regulatory domain (TRD).